Evaluation of CRISPR/Cas9 System Effects on Knocking Out NEAT1 Gene in AGS Gastric Cancer Cell Line with Therapeutic Perspective
Authors:
- 6 August 2021
- journal article
- research article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 53 (3) , 623-631
Abstract
Aim Gastric cancer (GC) is one of the most common malignant tumors globally, with an increasing incidence rate. Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNAs) responsible for regulating cell cycle progression, apoptosis, cell growth, proliferation, and migration in various cells. The present survey was performed to assess the effects of NEAT1 gene knocking out by CRISPR/Cas9 system in human gastric cancer cells. Methods The CRISPR/Cas9 genome editing technique was used to knockout NEAT1 in AGS cells as a gastric cancer model. After the design and construction of the vector, transfection was performed. The expression levels of mRNA, the survival of cells, apoptosis, and cell migration were evaluated by real-time quantitative polymerase chain reaction, flow cytometry, and scratch wound. Results Degradation of NEAT1 by CRISPR/cas9 significantly suppressed the gene’s expression rate, arrested cell cycle in the G0/G1 phase, and a significant reduction in cell number in the S phase (P < 0.05). Degradation of NEAT1 by CRISPR/cas9 also restrained the ability to migrate in transfected cells compared to the control group (P < 0.01). Knockout of NEAT1 via impact on miR-34a gene expression induced apoptosis of AGS cells (P < 0.05) with increasing in the FAS level and total apoptosis (P < 0.001). Conclusions Findings suggest that NEAT1 plays a vital role in cellular mechanisms of GC’s occurrence and can serve as a new treatment target in GC.Keywords
This publication has 37 references indexed in Scilit:
- CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell LineBioNanoScience, 2016
- Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancerJournal of Cancer Research and Clinical Oncology, 2016
- Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomasWorld Journal of Surgical Oncology, 2016
- Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patientsAPMIS, 2015
- The plasma lncRNA acting as fingerprint in non-small-cell lung cancerTumor Biology, 2015
- NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancerOncotarget, 2015
- The role of MicroRNAs expression in laryngeal cancerOncotarget, 2015
- The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancerNature Communications, 2014
- Long non-coding RNAs in cancer: implications for personalized therapyCellular Oncology, 2014
- Medicinal Plants and Cancer ChemopreventionCurrent Drug Metabolism, 2008